85 related articles for article (PubMed ID: 22121786)
1. [Comparison study of model evaluation methods: normalized prediction distribution errors vs. visual predictive check].
Ren YP; Deng CH; Wang XP; Zhou TY; Lu W
Yao Xue Xue Bao; 2011 Sep; 46(9):1123-31. PubMed ID: 22121786
[TBL] [Abstract][Full Text] [Related]
2. Standardized visual predictive check versus visual predictive check for model evaluation.
Wang DD; Zhang S
J Clin Pharmacol; 2012 Jan; 52(1):39-54. PubMed ID: 21257797
[TBL] [Abstract][Full Text] [Related]
3. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.
Comets E; Brendel K; Mentré F
Comput Methods Programs Biomed; 2008 May; 90(2):154-66. PubMed ID: 18215437
[TBL] [Abstract][Full Text] [Related]
4. Comparison of robust criteria for D-optimal designs.
Foo LK; McGree J; Eccleston J; Duffull S
J Biopharm Stat; 2012; 22(6):1193-205. PubMed ID: 23075017
[TBL] [Abstract][Full Text] [Related]
5. A new equivalence based metric for predictive check to qualify mixed-effects models.
Jadhav PR; Gobburu JV
AAPS J; 2005 Oct; 7(3):E523-31. PubMed ID: 16353930
[TBL] [Abstract][Full Text] [Related]
6. Prediction discrepancies for the evaluation of nonlinear mixed-effects models.
Mentré F; Escolano S
J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):345-67. PubMed ID: 16284919
[TBL] [Abstract][Full Text] [Related]
7. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.
Bergstrand M; Hooker AC; Wallin JE; Karlsson MO
AAPS J; 2011 Jun; 13(2):143-51. PubMed ID: 21302010
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of different tests based on observations for external model evaluation of population analyses.
Brendel K; Comets E; Laffont C; Mentré F
J Pharmacokinet Pharmacodyn; 2010 Feb; 37(1):49-65. PubMed ID: 20033477
[TBL] [Abstract][Full Text] [Related]
9. Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy.
Maharaj AR; Wu H; Hornik CP; Arrieta A; James L; Bhatt-Mehta V; Bradley J; Muller WJ; Al-Uzri A; Downes KJ; Cohen-Wolkowiez M
J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):199-218. PubMed ID: 32323049
[TBL] [Abstract][Full Text] [Related]
10. Methods of robust design of nonlinear models with an application to pharmacokinetics.
Foo LK; Duffull S
J Biopharm Stat; 2010 Jul; 20(4):886-902. PubMed ID: 20496212
[TBL] [Abstract][Full Text] [Related]
11. Model-Based Residual Post-Processing for Residual Model Identification.
Ibrahim MMA; Nordgren R; Kjellsson MC; Karlsson MO
AAPS J; 2018 Jul; 20(5):81. PubMed ID: 29968184
[TBL] [Abstract][Full Text] [Related]
12. TK Modeler version 1.0, a Microsoft® Excel®-based modeling software for the prediction of diurnal blood/plasma concentration for toxicokinetic use.
McCoy AT; Bartels MJ; Rick DL; Saghir SA
Regul Toxicol Pharmacol; 2012 Jul; 63(2):333-43. PubMed ID: 22504463
[TBL] [Abstract][Full Text] [Related]
13. [Population pharmacokinetic modeling and evaluation of propofol from multiple centers].
Ye HB; Zheng H; Zhang XA; Chi XJ; Chen WY; Xu JG; Li JH; Rui JZ
Yao Xue Xue Bao; 2010 Dec; 45(12):1550-8. PubMed ID: 21351496
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
Jones HM; Barton HA; Lai Y; Bi YA; Kimoto E; Kempshall S; Tate SC; El-Kattan A; Houston JB; Galetin A; Fenner KS
Drug Metab Dispos; 2012 May; 40(5):1007-17. PubMed ID: 22344703
[TBL] [Abstract][Full Text] [Related]
15. External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.
Zhao W; Kaguelidou F; Biran V; Zhang D; Allegaert K; Capparelli EV; Holford N; Kimura T; Lo YL; Peris JE; Thomson A; van den Anker JN; Fakhoury M; Jacqz-Aigrain E
Br J Clin Pharmacol; 2013 Apr; 75(4):1068-80. PubMed ID: 23148919
[TBL] [Abstract][Full Text] [Related]
16. Influence of covariance between random effects in design for nonlinear mixed-effect models with an illustration in pediatric pharmacokinetics.
Dumont C; Chenel M; Mentré F
J Biopharm Stat; 2014; 24(3):471-92. PubMed ID: 24697342
[TBL] [Abstract][Full Text] [Related]
17. Visual Predictive Check in Models with Time-Varying Input Function.
Largajolli A; Bertoldo A; Campioni M; Cobelli C
AAPS J; 2015 Nov; 17(6):1455-63. PubMed ID: 26265094
[TBL] [Abstract][Full Text] [Related]
18. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
Bazzoli C; Retout S; Mentré F
Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
[TBL] [Abstract][Full Text] [Related]
19. Phenobarbital in intensive care unit pediatric population: predictive performances of population pharmacokinetic model.
Marsot A; Michel F; Chasseloup E; Paut O; Guilhaumou R; Blin O
Fundam Clin Pharmacol; 2017 Oct; 31(5):558-566. PubMed ID: 28407406
[TBL] [Abstract][Full Text] [Related]
20. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
Knights J; Rohatagi S
J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
